THE TGA has published new
Australian Public Assessment
Reports for prescription medicines
(AusPARs) on its website.
The new AusPARs relate to
Bristol-Myers Squibb Australia’s
Orencia (abatacept) and Helex-A’s
Oralair Sublingual Tablets (Allergen
Pollen Extract of 5 Grasses).
Other new AusPARs include
Biogen Idec Australia’s Ferric
carboxymaltose (Fampridine) and
Invida Australia’s Sancuso
(Granisetron).The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 11
NOSTRADATA’S Nick Biggs and Reem Borrows of Dreem Coaching and Consulting will co-headline a workshop titled ‘Beyond the Counter: Using your Data to Maximise Business Performance’ at the APP2024 conference.